Literature DB >> 12079244

Molecular cytogenetics as a diagnostic tool for typing melanocytic tumors.

Boris C Bastian1.   

Abstract

The melanocyte can give rise to a variety of both benign and malignant lesions that differ in their clinical and histopathological appearance. It is likely that genetic changes underlie this phenotypic diversity. Comparative genomic hybridization (CGH) is a genome-wide scanning technique that permits the measurement of copy number aberrations in archival tumors. Using CGH, we have demonstrated significant differences in the frequency of chromosomal aberrations in primary cutaneous melanomas and Spitz nevi. Whereas the majority of melanomas have aberrations frequently involving chromosomes 9, 10, 7, and 6, most Spitz nevi do not show aberrations. However, a small subset of Spitz nevi show an isolated gain of the short arm of chromosome 11p. As this aberration has not been observed in melanomas, the measurement of chromosomal aberrations should be further evaluated as a diagnostic tool for ambiguous melanocytic tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079244     DOI: 10.1007/978-3-642-59410-6_13

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  4 in total

1.  Comparative genomic hybridization in a case of melanoma that loses expression of S100, HMB45, Melan A and tyrosinase in metastasis.

Authors:  Ruifeng Guo; Xianfu Wang; Jie Chen; Ellizabeth Gillies; Kar-Ming Fung; Shibo Li; Lewis A Hassell
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

2.  Molecular-microscopical correlation in dermatopathology.

Authors:  Timothy H McCalmont; Swapna Vemula; Peter Sands; Boris C Bastian
Journal:  J Cutan Pathol       Date:  2011-04       Impact factor: 1.587

Review 3.  [Molecular diagnosis of melanocytic tumors].

Authors:  J Bauer
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

4.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.